Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Polli

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|September 25, 1991
Calmodulin-dependent protein phosphatase from Neurospora crassa. Molecular cloning and expression of recombinant catalytic subunitS Higuchi, J Tamura, P R Giri, et al.
Brain Research. Developmental Brain Research|February 21, 1992
Distribution and expression of SNAP-25 immunoreactivity in rat brain, rat PC-12 cells and human SMS-KCNR neuroblastoma cellsG A Oyler, J W Polli, G A Higgins, et al.
Pharmaceutical Research|April 17, 2001
Influence of passive permeability on apparent P-glycoprotein kineticsK A Lentz, J W Polli, S A Wring, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2001
Induction of P-glycoprotein and cytochrome P450 3A by HIV protease inhibitorsL Huang, S A Wring, J L Woolley, et al.
Biochemical Pharmacology|October 6, 1999
P-glycoprotein-mediated transport of morphine in brain capillary endothelial cellsS P Letrent, J W Polli, J E Humphreys, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter ConsortiumD Tweedie, J W Polli, E Gil Berglund, et al.
Pharmacogenetics|October 19, 2000
Prospective CYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trialM P Murphy, M E Beaman, L S Clark, et al.
Pharmaceutical Research|September 1, 1999
Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitorJ W Polli, J L Jarrett, S D Studenberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
Rational use of in vitro P-glycoprotein assays in drug discoveryJ W Polli, S A Wring, J E Humphreys, et al.
Toxicology and Applied Pharmacology|September 20, 2015
Toxicokinetics and toxicity of atorvastatin in dogsC E Herron, C C Brueckner, J P Chism, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|September 25, 1991
Calmodulin-dependent protein phosphatase from Neurospora crassa. Molecular cloning and expression of recombinant catalytic subunitS Higuchi, J Tamura, P R Giri, et al.
Brain Research. Developmental Brain Research|February 21, 1992
Distribution and expression of SNAP-25 immunoreactivity in rat brain, rat PC-12 cells and human SMS-KCNR neuroblastoma cellsG A Oyler, J W Polli, G A Higgins, et al.
Pharmaceutical Research|April 17, 2001
Influence of passive permeability on apparent P-glycoprotein kineticsK A Lentz, J W Polli, S A Wring, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2001
Induction of P-glycoprotein and cytochrome P450 3A by HIV protease inhibitorsL Huang, S A Wring, J L Woolley, et al.
Biochemical Pharmacology|October 6, 1999
P-glycoprotein-mediated transport of morphine in brain capillary endothelial cellsS P Letrent, J W Polli, J E Humphreys, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter ConsortiumD Tweedie, J W Polli, E Gil Berglund, et al.
Pharmacogenetics|October 19, 2000
Prospective CYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trialM P Murphy, M E Beaman, L S Clark, et al.
Pharmaceutical Research|September 1, 1999
Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitorJ W Polli, J L Jarrett, S D Studenberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
Rational use of in vitro P-glycoprotein assays in drug discoveryJ W Polli, S A Wring, J E Humphreys, et al.
Toxicology and Applied Pharmacology|September 20, 2015
Toxicokinetics and toxicity of atorvastatin in dogsC E Herron, C C Brueckner, J P Chism, et al.
Pageof 3